WO2001074809A1 - Derives d'acylthiophene et leur utilisation en tant que medicaments - Google Patents
Derives d'acylthiophene et leur utilisation en tant que medicaments Download PDFInfo
- Publication number
- WO2001074809A1 WO2001074809A1 PCT/JP2001/002705 JP0102705W WO0174809A1 WO 2001074809 A1 WO2001074809 A1 WO 2001074809A1 JP 0102705 W JP0102705 W JP 0102705W WO 0174809 A1 WO0174809 A1 WO 0174809A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- derivatives
- acylthiophene
- blood cells
- drugs
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des dérivés d'acylthiophène comprenant, généralement, le composé de formule (I), ou des sels de ceux-ci, acceptables au plan pharmaceutique. L'invention porte également sur des médicaments contenant lesdits dérivés ou sels en tant que principe actif. Lesdits dérivés induisent la production de plaquettes, de leucocytes, d'érythrocytes ou similaire, et sont utiles dans la chimiothérapie du cancer, la radiothérapie, la thérapie par greffe de moelle osseuse ou la pharmacothérapie ainsi que dans la prévention ou le traitement de la cytopénie consécutive à des troubles immunitaires, à l'anémie ou similaire.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000093610 | 2000-03-30 | ||
JP2000-093610 | 2000-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001074809A1 true WO2001074809A1 (fr) | 2001-10-11 |
Family
ID=18608772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/002705 WO2001074809A1 (fr) | 2000-03-30 | 2001-03-30 | Derives d'acylthiophene et leur utilisation en tant que medicaments |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2001074809A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100348591C (zh) * | 2004-07-15 | 2007-11-14 | 浙江海正集团有限公司 | 取代亚甲基吡喃酮类衍生物及其制备方法和用途 |
WO2011088152A1 (fr) | 2010-01-12 | 2011-07-21 | Portola Pharmaceuticals, Inc. | Composition pharmaceutique et forme galénique de l'élinogrel et leurs méthodes d'application |
CN1990478B (zh) * | 2005-12-26 | 2011-08-31 | 浙江海正药业股份有限公司 | 6-芳基-3-取代亚甲基吡喃酮类化合物及其制备方法和用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0841063A1 (fr) * | 1996-03-27 | 1998-05-13 | Toray Industries, Inc. | Derives de cetone et usage medicinal |
EP0962456A1 (fr) * | 1997-09-26 | 1999-12-08 | Toray Industries, Inc. | Derive de cetone et son utilisation en medecine |
-
2001
- 2001-03-30 WO PCT/JP2001/002705 patent/WO2001074809A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0841063A1 (fr) * | 1996-03-27 | 1998-05-13 | Toray Industries, Inc. | Derives de cetone et usage medicinal |
EP0962456A1 (fr) * | 1997-09-26 | 1999-12-08 | Toray Industries, Inc. | Derive de cetone et son utilisation en medecine |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100348591C (zh) * | 2004-07-15 | 2007-11-14 | 浙江海正集团有限公司 | 取代亚甲基吡喃酮类衍生物及其制备方法和用途 |
CN1990478B (zh) * | 2005-12-26 | 2011-08-31 | 浙江海正药业股份有限公司 | 6-芳基-3-取代亚甲基吡喃酮类化合物及其制备方法和用途 |
WO2011088152A1 (fr) | 2010-01-12 | 2011-07-21 | Portola Pharmaceuticals, Inc. | Composition pharmaceutique et forme galénique de l'élinogrel et leurs méthodes d'application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ543661A (en) | Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation | |
HK1053115A1 (en) | Quinazoline derivatives for the treatment of tumours. | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
SG127738A1 (en) | Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, pharmaceutical preparations containing these compounds | |
CY1110395T1 (el) | Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης | |
WO2004112711A3 (fr) | Composition orale a liberation prolongee | |
MXPA06000302A (es) | Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden. | |
CA2386775A1 (fr) | Medicaments de traitement de tumeurs malignes | |
EP1213026A4 (fr) | Agents contenant du ginseng destines a proteger les cellules cerebrales ou les cellules nerveuses | |
NO20063277L (no) | Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav | |
HUP9900386A2 (hu) | Fenoxi-piridin-származékok alkalmazása szívelégtelenség kezelésére alkalmas gyógyszerkészítmények előállítására | |
MY128014A (en) | Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors | |
WO2005014572A8 (fr) | Derives de pyrimidylpyrrole pouvant etre utilises comme inhibiteurs de kinases | |
WO2002088100A3 (fr) | 3-piperidinopropiophenones dopees et produits pharmaceutiques contenant ces composes | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
IT1226727B (it) | Farmaci precursori della dopamina. | |
UA86776C2 (ru) | Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение | |
MY133112A (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use | |
HK1068348A1 (en) | Therapeutic heterocycles as bradykinin b2 receptorantagonists | |
ATE326451T1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
WO2001074809A1 (fr) | Derives d'acylthiophene et leur utilisation en tant que medicaments | |
TW200612914A (en) | Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents | |
EP0962456A4 (fr) | Derive de cetone et son utilisation en medecine | |
EP0980867A4 (fr) | Derives de cetones et leur utilisation en medecine | |
WO2004073627A3 (fr) | Methode et compositions therapeutiques pour administration topique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA CN JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |